Canada Pension Plan Investment Board’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.27M | Sell |
70,800
-1,172,000
| -94% | -$22.2M | ﹤0.01% | 970 |
|
|
2026
Q1 | $27M | Buy |
1,242,800
+895,971
| +258% | +$17.3M | 0.02% | 454 |
|
|
2025
Q4 | $7.46M | Buy |
346,829
+25,100
| +8% | +$529K | 0.01% | 709 |
|
|
2025
Q3 | $6.2M | Buy |
321,729
+230,129
| +251% | +$4.1M | ﹤0.01% | 728 |
|
|
2025
Q2 | $1.57M | Buy |
+91,600
| New | +$3.91M | ﹤0.01% | 919 |
|
|
2024
Q3 | – | Sell |
-230,300
| Closed | -$36.4M | – | 1463 |
|
|
2024
Q2 | $36.4M | Sell |
230,300
-10,200
| -4% | -$1.31M | 0.04% | 332 |
|
|
2024
Q1 | $31.1M | Buy |
240,500
+230,300
| +2,258% | +$28.2M | 0.03% | 369 |
|
|
2023
Q4 | $984K | Sell |
10,200
-135,524
| -93% | -$13M | ﹤0.01% | 953 |
|
|
2023
Q3 | $17.7M | Buy |
145,724
+125,324
| +614% | +$14.2M | 0.03% | 405 |
|
|
2023
Q2 | $2.34M | Sell |
20,400
-18,200
| -47% | -$2.35M | ﹤0.01% | 698 |
|
|
2023
Q1 | $5.32M | Sell |
38,600
-27,500
| -42% | -$3.57M | 0.01% | 570 |
|
|
2022
Q4 | $8.57M | Buy |
66,100
+2,000
| +3% | +$232K | 0.02% | 430 |
|
|
2022
Q3 | $7.09M | Buy |
64,100
+18,600
| +41% | +$1.87M | 0.01% | 480 |
|
|
2022
Q2 | $3.41M | Buy |
45,500
+39,556
| +665% | +$2.91M | 0.01% | 594 |
|
|
2022
Q1 | $464K | Sell |
5,944
-48,689
| -89% | -$3.73M | ﹤0.01% | 946 |
|
|
2021
Q4 | $4.92M | Buy |
54,633
+17,367
| +47% | +$1.48M | 0.01% | 712 |
|
|
2021
Q3 | $3.45M | Buy |
+37,266
| New | +$2.87M | ﹤0.01% | 745 |
|
|
2021
Q2 | – | Sell |
-4,896
| Closed | -$365K | – | 1348 |
|
|
2021
Q1 | $365K | Buy |
+4,896
| New | +$452K | ﹤0.01% | 1093 |
|
|
2020
Q3 | – | Sell |
-3,082
| Closed | -$494K | – | 1337 |
|
|
2020
Q2 | $494K | Buy |
+3,082
| New | +$419K | ﹤0.01% | 1069 |
|
|
2020
Q1 | – | Sell |
-1,208
| Closed | -$156K | – | 1466 |
|
|
2019
Q4 | $156K | Buy |
+1,208
| New | +$122K | ﹤0.01% | 1290 |
|
|
2018
Q2 | – | Sell |
-15,800
| Closed | -$1.17M | – | 1291 |
|
|
2018
Q1 | $1.17M | Sell |
15,800
-4,900
| -24% | -$327K | ﹤0.01% | 1052 |
|
|
2017
Q4 | $1.15M | Sell |
20,700
-9,400
| -31% | -$498K | ﹤0.01% | 965 |
|
|
2017
Q3 | $1.36M | Buy |
30,100
+11,400
| +61% | +$456K | ﹤0.01% | 902 |
|
|
2017
Q2 | $630K | Buy |
+18,700
| New | +$609K | ﹤0.01% | 968 |
|
|
2016
Q2 | – | Sell |
-23,400
| Closed | -$457K | – | 1154 |
|
|
2016
Q1 | $457K | Sell |
23,400
-91,600
| -80% | -$1.6M | ﹤0.01% | 924 |
|
|
2015
Q4 | $4.44M | Buy |
115,000
+81,100
| +239% | +$2.63M | 0.02% | 555 |
|
|
2015
Q3 | $1.09M | Buy |
33,900
+6,300
| +23% | +$214K | ﹤0.01% | 835 |
|
|
2015
Q2 | $840K | Buy |
+27,600
| New | +$564K | ﹤0.01% | 868 |
|
|
2015
Q1 | – | Sell |
-1,700
| Closed | -$25K | – | 1270 |
|
|
2014
Q4 | $25K | Buy |
+1,700
| New | +$28.8K | ﹤0.01% | 1263 |
|
Other funds holding SRPT
EAM
Canada Pension Plan Investment Board's SRPT Position: Q2 2026 in Review
Canada Pension Plan Investment Board reduced its Sarepta Therapeutics (SRPT) stake by 94% in Q2 2026, selling an estimated $22.2M and leaving 70,800 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #970.
Canada Pension Plan Investment Board first reported a position in SRPT in Q4 2014 and has held it in 29 quarters since. The position peaked at $36.4M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Canada Pension Plan Investment Board held 70,800 shares of Sarepta Therapeutics worth $1.27M as of Q2 2026.
- Canada Pension Plan Investment Board sold 1,172,000 Sarepta Therapeutics shares in Q2 2026, an estimated $22.2M.
- Sarepta Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #970 holding.
- Canada Pension Plan Investment Board first reported a position in Sarepta Therapeutics in Q4 2014 and has held it in 29 quarters since.
- Canada Pension Plan Investment Board's Sarepta Therapeutics position peaked at $36.4M in Q2 2024.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.